Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Pancreatic stellate cells (PSCs) differentiate into cancer-associated fibroblasts (CAFs) that produce desmoplastic stroma, thereby modulating disease progression and therapeutic response in pancreatic ductal adenocarcinoma (PDA). However, it is unknown whether CAFs uniformly carry out these tasks or if subtypes of CAFs with distinct phenotypes in PDA exist. We identified a CAF subpopulation with elevated expression of α-smooth muscle actin (αSMA) located immediately adjacent to neoplastic cells in mouse and human PDA tissue. We recapitulated this finding in co-cultures of murine PSCs and PDA organoids, and demonstrated that organoid-activated CAFs produced desmoplastic stroma. The co-cultures showed cooperative interactions and revealed another distinct subpopulation of CAFs, located more distantly from neoplastic cells, which lacked elevated αSMA expression and instead secreted IL6 and additional inflammatory mediators. These findings were corroborated in mouse and human PDA tissue, providing direct evidence for CAF heterogeneity in PDA tumor biology with implications for disease etiology and therapeutic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, TGF-β influences CAF expression of cytokines and chemokines that act on cancer, endothelial and/or immune cells, such as HGF245, VEGF, IL-6, IL-8, MCP1, PGE2 and CXCL12229,257–262.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [229]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In pancreatic cancer, CAFs most proximal to the cancer cells exhibit a myoCAF phenotype, with high TGFβ-driven αSMA expression and a contractile phenotype33.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“With respect to CAFs and pancreatic cancer, it has been established that coculture of murine PSCs and PDAC tumor organoids leads to CAF differentiation into two subtypes -one with elevated expression of α -SMA (myo fi broblast-like CAFs) and the other with high expression of IL-6 (in fl ammatory CAFs) [61].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“CAFs that are in close proximity to cancer cells present a myo fi broblast-like phenotype (myCAF) de fi ned by a high expression of α -SMA”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“whereas CAFs distant from cancer cells barely express α -SMA but secrete high amounts of in fl ammatory cytokine IL-6 (iCAF)”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationCre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Self-citation
Cited by
Items 601–700 of 1,008
Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC
Sharma, M., Turaga, R. C., Yuan, Y., Satyanarayana, G., Mishra, F., Bian, Z., Liu, W., Sun, L. Z., Yang, J. J., & Liu, Z. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200712 · Cited by 64
Venning, F. A., Zornhagen, K. W., Wullkopf, L., Sjölund, J., Rodriguez-Cupello, C., Kjellman, P., Morsing, M., Hajkarim, M. C., Won, K., Erler, J. T., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01944-4 · Cited by 65
Pan, X., Zhou, J., Xiao, Q., Fujiwara, K., Zhang, M., Mo, G., Gong, W., & Zheng, L. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01203-1 · Cited by 62
Liu, X., Lu, Y., Huang, J., Xing, Y., Dai, H., Zhu, L., Li, S., Feng, J., Zhou, B., Li, J., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.10.015 · Cited by 63
Fibroblasts in immune responses, inflammatory diseases and therapeutic implications
Zou, A. E., Kongthong, S., Mueller, A. A., & Brenner, M. B. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01259-0 · Cited by 68
Ham, I., Lee, D., & Hur, H. (2021) · Cancers · doi:10.3390/cancers13051172 · Cited by 64
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
Franchi-Mendes, T., Eduardo, R., Domenici, G., & Brito, C. (2021) · Cancers · doi:10.3390/cancers13184610 · Cited by 67
Mezawa, Y., & Orimo, A. (2021) · FEBS Journal · doi:10.1111/febs.15851 · Cited by 61
Li, Y., Xiang, S., Pan, W., Wang, J., Zhan, H., & Liu, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1166860 · Cited by 72
Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling
Agorku, D., Bosio, A., Alves, F., Ströbel, P., & Hardt, O. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216985 · Cited by 59
Crosstalk between CAFs and tumour cells in head and neck cancer
Li, X., González-Maroto, C., & Tavassoli, M. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02053-9 · Cited by 74
Loveless, I. M., Kemp, S. B., Hartway, K. M., Mitchell, J. T., Wu, Y., Zwernik, S. D., Salas-Escabillas, D. J., Brender, S. M., George, M., Makinwa, Y., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2183 · Cited by 68
Zhang, X., Ren, B., Liu, B., Wang, R. Y., Li, S., Zhao, Y., & Zhou, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06376-8 · Cited by 76
Wang, W., Hu, K., Xue, J., Chen, J., Du, X., Zhao, T., Chen, Y., Tang, X., Lü, X. C., Hao, X., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113888 · Cited by 64
A novel pancreatic tumour and stellate cell 3D co-culture spheroid model
Norberg, K. J., Liu, X., Fernández Moro, C., Strell, C., Nania, S., Blümel, M., Balboni, A., Bozóky, B., Heuchel, R. L., & Löhr, J. M. (2020) · BMC Cancer · doi:10.1186/s12885-020-06867-5 · Cited by 56
Sirica, A. E., Strazzabosco, M., & Cadamuro, M. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.005 · Cited by 62
Shiota, J., Samuelson, L. C., & Razumilava, N. (2021) · Hepatology · doi:10.1002/hep.31772 · Cited by 56
Zhu, K., Cai, L., Cui, C., Toyos, J. R. D. L., & Anastassiou, D. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009228 · Cited by 63
Extracellular matrix in cancer progression and therapy
He, X., Lee, B., & Jiang, Y. (2022) · Medical Review · doi:10.1515/mr-2021-0028 · Cited by 73
Capula, M., Perán, M., Xu, G., Donati, V. L., Yee, D., Gregori, A., Assaraf, Y. G., Giovannetti, E., & Deng, D. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100864 · Cited by 57
Dixit, A. K., Sarver, A. G., Zettervall, J., Huang, H., Zheng, K., Brekken, R. A., & Provenzano, P. P. (2022) · JCI Insight · doi:10.1172/jci.insight.153242 · Cited by 64
CAF-immune cell crosstalk and its impact in immunotherapy
Maia, A. R. R., Schöllhorn, A., Schuhmacher, J., & Gouttefangeas, C. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00977-x · Cited by 63
Owen, J. S., Clayton, A., & Pearson, H. B. (2022) · Biomolecules · doi:10.3390/biom13010067 · Cited by 66
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression
Tomecka, P., Kunachowicz, D., Górczyńska, J., Gebuza, M., Kuźnicki, J., Skinderowicz, K., & Choromańska, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168972 · Cited by 67
The fibroinflammatory response in cancer
Xiao, Z., & Puré, E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00798-8 · Cited by 74
The extracellular matrix in cancer: from understanding to targeting
Chitty, J. L., & Cox, T. R. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.05.003 · Cited by 71
Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies
Harryvan, T. J., Verdegaal, E. M. E., Hardwick, J. C. H., Hawinkels, L. J. A. C., & van der Burg, S. H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111989 · Cited by 57
Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer
Bausch, D., Fritz, S., Bolm, L., Wellner, U. F., Fernández‐del‐Castillo, C., Warshaw, A. L., Thayer, S. P., & Liss, A. S. (2020) · Angiogenesis · doi:10.1007/s10456-020-09725-x · Cited by 57
Islam, S., Kitagawa, T., Baron, B., Abiko, Y., Chiba, I., & Kuramitsu, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-90077-x · Cited by 56
NF-κB and Pancreatic Cancer; Chapter and Verse
Silke, J., & O’Reilly, L. A. (2021) · Cancers · doi:10.3390/cancers13184510 · Cited by 57
Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer
Banerjee, P., Kotla, S., Velatooru, L. R., Abe, R. J., Olmsted‐Davis, E. A., Cooke, J. P., Schadler, K., Deswal, A. M., Herrmann, J., Lin, S. H., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.763930 · Cited by 57
The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer
Ohara, Y., Valenzuela, P., & Hussain, S. P. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.004 · Cited by 60
Fight the Cancer, Hit the CAF!
Papait, A., Romoli, J., Stefani, F. R., Chiodelli, P., Montresor, M. C., Agoni, L., Silini, A. R., & Parolini, O. (2022) · Cancers · doi:10.3390/cancers14153570 · Cited by 60
Schütz, S., Solé‐Boldo, L., Lucena-Porcel, C., Hoffmann, J. H. O., Brobeil, A., Lonsdorf, A. S., Rodríguez‐Paredes, M., & Lyko, F. (2023) · Nature Communications · doi:10.1038/s41467-023-41141-9 · Cited by 60
Mazzeo, L., Ghosh, S., Cicco, E. D., Isma, J., Tavernari, D., Samarkina, A., Ostano, P., Youssef, M. K., Simon, C., & Dotto, G. P. (2024) · Nature Communications · doi:10.1038/s41467-024-45308-w · Cited by 57
Fibroblasts in Diabetic Foot Ulcers
Voza, F. A., Huerta, C. T., Le, N., Shao, H., Ribieras, A. J., Ortiz, Y. Y., Atkinson, C., Machuca, T., Liu, Z., & Velazquez, O. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042172 · Cited by 67
Honda, C., Kurozumi, S., Fujii, T., Pourquier, D., Khellaf, L., Boissière‐Michot, F., Horiguchi, J., Oyama, T., Shirabe, K., Colinge, J., et al. (2024) · Theranostics · doi:10.7150/thno.90627 · Cited by 66
Cumming, J., Maneshi, P., Dongre, M., Alsaed, T., Dehghan-Nayeri, M. J., Ling, A., Pietras, K., Patthey, C., & Öhlund, D. (2025) · Cancer Research · doi:10.1158/0008-5472.can-23-3252 · Cited by 75
Self-citationOrganoid of ovarian cancer: genomic analysis and drug screening
Liu, H., Xia, B., Jin, M., & Lou, G. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02276-8 · Cited by 61
Cancer associated fibroblast: Mediators of tumorigenesis
Alexander, J. I., & Cukierman, E. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.05.004 · Cited by 58
Geng, X., Li, L., Luo, Y., Yang, W., Hu, J., Zhao, Z., Cheng, C., Zhang, T., Zhang, Y., Liu, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202203324 · Cited by 57
Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response
Lior, C., Barki, D., Halperin, C., Iacobuzio–Donahue, C. A., Kelsen, D. P., & Scherz‐Shouval, R. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114236 · Cited by 62
A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer
Coppola, S., Carnevale, I., Danen, E. H. J., Peters, G. J., Schmidt, T., Assaraf, Y. G., & Giovannetti, E. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.07.001 · Cited by 56
Validation and comparison of the molecular classifications of pancreatic carcinomas
Birnbaum, D. J., Finetti, P., Birnbaum, D., Mamessier, É., & Bertucci, F. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0739-z · Cited by 63
Mezawa, Y., Daigo, Y., Takano, A., Miyagi, Y., Yokose, T., Yamashita, T., Morimoto, C., Hino, O., & Orimo, A. (2019) · Cancer Medicine · doi:10.1002/cam4.2249 · Cited by 58
Pancreatic Cancer and Its Microenvironment—Recent Advances and Current Controversies
Stopa, K. B., Kusiak, A. A., Szopa, M. D., Ferdek, P. E., & Jakubowska, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093218 · Cited by 59
Mucciolo, G., Curcio, C., Roux, C., Li, W. Y., Capello, M., Curto, R., Chiarle, R., Giordano, D., Satolli, M. A., Lawlor, R. T., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020395118 · Cited by 57
Rubinstein-Achiasaf, L., Morein, D., Ben-Yaakov, H., Liubomirski, Y., Meshel, T., Elbaz, E., Dorot, O., Pichinuk, E., Gershovits, M., Weil, M., et al. (2021) · Cancers · doi:10.3390/cancers13061472 · Cited by 61
Pre-clinical Models of Metastasis in Pancreatic Cancer
Miquel, M., Zhang, S., & Pilarsky, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748631 · Cited by 53
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
Miyai, Y., Sugiyama, D., Hase, T., Asai, N., Taki, T., Nishida, K., Fukui, T., Chen-Yoshikawa, T. F., Kobayashi, H., Mii, S., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202101230 · Cited by 59
Akkız, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043941 · Cited by 60
Fibroblasts as Turned Agents in Cancer Progression
Wieder, R. (2023) · Cancers · doi:10.3390/cancers15072014 · Cited by 57
Epigenetic regulation of cancer-associated fibroblast heterogeneity
Kehrberg, R. J., Bhyravbhatla, N., Batra, S. K., & Kumar, S. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188901 · Cited by 59
Gao, D., Fang, L., Liu, C., Yang, M., Yu, X., Wang, L., Zhang, W., Sun, C., & Zhuang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115622 · Cited by 61
Dynamic fibroblast–immune interactions shape recovery after brain injury
Ewing-Crystal, N. A., Mroz, N. M., Larpthaveesarp, A., Lizama, C. O., Pennington, R., Chiaranunt, P., Dennis, J. I., Chang, A. A., Merrill, E. D., Caryotakis, S. E., et al. (2025) · Nature · doi:10.1038/s41586-025-09449-2 · Cited by 68
Cancer-Associated Fibroblasts’ Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma
Awaji, M. I., & Singh, R. K. (2019) · Cancers · doi:10.3390/cancers11030290 · Cited by 56
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Schmiechen, Z. C., & Stromnes, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613815 · Cited by 66
Cancer-Associated Fibroblasts: Implications for Cancer Therapy
Maia, A. R. R., & Wiemann, S. (2021) · Cancers · doi:10.3390/cancers13143526 · Cited by 63
Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy
De, P. K., Aske, J. C., & Dey, N. (2021) · Cancers · doi:10.3390/cancers13205246 · Cited by 57
Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment
Bhatia, R., Bhyravbhatla, N., Kisling, A., Li, X., Batra, S. K., & Kumar, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.021 · Cited by 57
Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance
Darvishi, B., Eisavand, M. R., Majidzadeh‐A, K., & Farahmand, L. (2022) · British Journal of Cancer · doi:10.1038/s41416-021-01680-8 · Cited by 56
STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer
Lefler, J. E., MarElia, C. B., Thies, K., Hildreth, B. E., Sharma, S. M., Pitarresi, J. R., Han, L., Everett, C., Koivisto, C. S., Cuitiño, M. C., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202201460 · Cited by 57
Simitian, G. S., Virumbrales-Muñoz, M., Sánchez‐de‐Diego, C., Beebe, D. J., & Kosoff, D. (2022) · Lab on a Chip · doi:10.1039/d2lc00352j · Cited by 56
Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC
Xie, J., Zheng, S., Zou, Y., Tang, Y., Tian, W., Wong, C., Wu, S., Ou, X., Zhao, W., Cai, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1022147 · Cited by 60
Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma
Mascharak, S., Guo, J. L., Foster, D. S., Khan, A., Davitt, M. F., Nguyen, A. T., Burcham, A. R., Chinta, M. S., Guardino, N. J., Griffin, M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101248 · Cited by 66
Basalova, N. A., Alexandrushkina, N. A., Grigorieva, O., Kulebyakina, M., & Efimenko, A. Y. (2023) · Biomolecules · doi:10.3390/biom13121718 · Cited by 58
Cancer-associated fibroblasts in cholangiocarcinoma
Vaquero, J., Aoudjehane, L., & Fouassier, L. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000609 · Cited by 52
Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer
Lee, Y. T., Tan, Y. J., Falasca, M., & Oon, C. E. (2020) · Cancers · doi:10.3390/cancers12102949 · Cited by 51
Park, M., Kwon, J., Kong, J., Moon, S. M., Cho, S., Yang, K. Y., Jang, W. I., Kim, M., Kim, Y., & Shin, U. S. (2021) · Cancers · doi:10.3390/cancers13153760 · Cited by 54
Huang, H., Sung, Y., Li, C., Wan, D., Chao, P., Tseng, Y., Liao, B.-W., Cheng, H., Hsu, F., Huang, C., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-325180 · Cited by 54
Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions
Jenkins, B. H., Buckingham, J. F., Hanley, C. J., & Thomas, G. J. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108231 · Cited by 57
Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment
Zhang, J., Huang, L., Ge, G., & Hu, K. (2023) · Advanced Science · doi:10.1002/advs.202206169 · Cited by 63
Hu, K. H., Kuhn, N. F., Courau, T., Tsui, J. L., Samad, B., Ha, P. K., Kratz, J. R., Combes, A. J., & Krummel, M. F. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.05.001 · Cited by 56
Yan, W., Menjivar, R. E., Bonilla, M. E., Steele, N. G., Kemp, S. B., Du, W., Donahue, K. L., Brown, K. L., Carpenter, E. S., Avritt, F. R., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0037 · Cited by 54
The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors
Bolm, L., Cigolla, S., Wittel, U. A., Hopt, U. T., Keck, T., Rades, D., Bronsert, P., & Wellner, U. F. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.04.009 · Cited by 52
Dzobo, K., Senthebane, D. A., Thomford, N. E., Rowe, A., Dandara, C., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0174 · Cited by 55
Pericyte Plasticity in the Brain
Santos, G. S. P., Magno, L. A. V., Romano‐Silva, M. A., Mintz, A., & Birbrair, A. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0296-5 · Cited by 56
Chen, X., Yu, Q., Liu, Y., Sheng, Q., Shi, K., Wang, Y., Li, M., Zhang, Z., & He, Q. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.003 · Cited by 53
Traub, B., Link, K. H., & Kornmann, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.030 · Cited by 57
Loh, J. J., & Ma, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.727640 · Cited by 53
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Deng, D., Patel, R. H., Chiang, C.-Y., & Hou, P. (2022) · Cells · doi:10.3390/cells11192952 · Cited by 60
Mechanisms of colorectal liver metastasis development
Shasha, T., Gruijs, M., & van Egmond, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04630-6 · Cited by 57
Zhang, Y., Ware, M. B., Zaidi, M. Y., Ruggieri, A. N., Olson, B. M., Komar, H. M., Farren, M. R., Nagaraju, G. P., Zhang, C., Chen, Z., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0911 · Cited by 57
Kesh, K., Garrido, V. T., Dosch, A. R., Durden, B. C., Gupta, V. K., Sharma, N., Lyle, M. P. A., Nagathihalli, N. S., Merchant, N. B., Saluja, A. K., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03168-4 · Cited by 49
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 58
Irvine, A. F., Waise, S., Green, E. W., Stuart, B. L., & Thomas, G. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-81796-2 · Cited by 55
Sunami, Y., Boeker, V., & Kleeff, J. H. (2021) · Cancers · doi:10.3390/cancers13040697 · Cited by 58
Organoid co‐culture models of the tumor microenvironment promote precision medicine
Gu, Z., Wu, Q., Shang, B., Zhang, K., & Zhang, W. (2024) · Cancer Innovation · doi:10.1002/cai2.101 · Cited by 47
McCubrey, J. A., Yang, L. V., Abrams, S. L., Steelman, L. S., Follo, M. Y., Cocco, L., Ratti, S., Martelli, A. M., Augello, G., & Cervello, M. (2022) · Cells · doi:10.3390/cells11142155 · Cited by 49
Evans, R. M., & Lippman, S. M. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.09.007 · Cited by 51
Zhou, T., Liu, J., Xie, Y., Yuan, S., Guo, Y. L., Bai, W., Zhao, K., Jiang, W., Wang, H., Wang, H., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321952 · Cited by 62
Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer
Huang, C., Iovanna, J., & Santofimia‐Castaño, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094970 · Cited by 61
Gastrointestinal cancer organoids—applications in basic and translational cancer research
Seidlitz, T., & Stange, D. E. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00654-3 · Cited by 58
Bhome, R., Emaduddin, M., James, V. H., House, L. M., Thirdborough, S. M., Mellone, M., Tulkens, J., Primrose, J. N., Thomas, G. J., Wever, O. D., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12226 · Cited by 53
Mercanti, L., Sindaco, M., Mazzone, M., Marcantonio, M. C. D., Piscione, M., Muraro, R., & Mincione, G. (2023) · Cancers · doi:10.3390/cancers15112923 · Cited by 62
The immunometabolic ecosystem in cancer
Bantug, G. R., & Hess, C. (2023) · Nature Immunology · doi:10.1038/s41590-023-01675-y · Cited by 61
Li, E., Cheung, H. C., & Ma, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-68109-z · Cited by 67
Timperi, E., Croizer, H., Khantakova, D., Rana, M., Molgora, M., Guerriero, J. L., Mechta-Grigoriou, F., & Romano, E. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1690 · Cited by 49
Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer
Zhang, Y., Li, L., Murad, R., Maganti, S., Manceau, A., Faso, H. A., Neff, M., Galapate, C. M., Grenier, S. F., Carrette, F., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.06.021 · Cited by 67
Stroma-derived extracellular vesicles deliver tumor-suppressive miRNAs to pancreatic cancer cells
Han, S., Gonzalo, D. H., Feely, M., Rinaldi, C., Belsare, S., Zhai, H., Kalra, K., Gerber, M. H., Forsmark, C. E., & Hughes, S. J. (2017) · Oncotarget · doi:10.18632/oncotarget.23532 · Cited by 52
Metadata
- Authors
- Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., Chio, I. I. C., Hwang, C.-I., Tiriac, H., Baker, L. A., Engle, D. D., Feig, C., Kultti, A., Egeblad, M., Fearon, D. T., Crawford, J. M., Clevers, H., Park, Y., & Tuveson, D. A.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 1
- University of Verona (IT)
- University of Cambridge (GB)
- Hofstra University (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- ORCID
- Öhlund, Daniel
- Biffi, Giulia
- Almeida, Ana S.
- Corbo, Vincenzo
- Oni, Tobiloba E.
- Hearn, Stephen A.
- Lee, Eun Jung
- Chio, Iok In Christine
- Hwang, Chang-Il
- Tiriac, Hervé
- Baker, Lindsey A.
- Engle, Dannielle D.
- Feig, Christine
- Kultti, Anne
- Egeblad, Mikala
- Fearon, Douglas T.
- Crawford, James M.
- Clevers, Hans
- Park, Youngkyu
- Tuveson, David A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-02-23
- Volume
- 214
- Issue
- 3
- Pages
- 579-596
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5339682
- OpenAlex
- W2590390825
- Cited by
- 2,590
- References
- 58
- Citations by year
- 2026: 349 · 2025: 333 · 2024: 350 · 2023: 343 · 2022: 335 · 2021: 349 · 2020: 260 · 2019: 144 · 2018: 89 · 2017: 36
- FWCI
- 64.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Cork Open Research Archive (University College Cork, Ireland) (acceptedVersion, cc-by)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Lustgarten Foundation
- National Institutes of Health (5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-02, 5U01CA168409-5, 1R01CA188134, 1R01CA190092-03, R50CA311506-01, CA101955 UAB/UMN SPORE, 5T32CA148056, F32CA192904)
- Stand Up to Cancer
- STARR foundation (I7-A718)
- DOD (W81XWH-13-PRCRP-IA)
- Swedish Research Council (537-2013-7277)
- Kempe Foundations (JCK-1301)
- Swedish Society of Medicine (SLS-326921, SLS-250831, SLS-175991, SLS-591551)
- Cancer Research Foundation in Northern Sweden (AMP15-793, LP11-1927)
- Human Frontiers Science Program (LT000403/2014, LT000195/2015-L, LT000190/2013)
- Weizmann Institute of Science
- EMBO (ALTF 1203-2014)
- Italian Ministry of Health (FIRB - RBAP10AHJ)
- Associazione Italiana Ricerca Cancro (18718)
- Damon Runyon Cancer Research Foundation (DRG-2165-13)
- National Cancer Institute (1K99CA204725-01A1)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, cancer-associated fibroblasts, CAF heterogeneity, pancreatic stellate cells, myofibroblasts, desmoplastic stroma, alpha-smooth muscle actin, interleukin-6, tumor microenvironment, organoid co-culture, tumor-fibroblast interaction
- MeSH terms
- Actins, Animals, Cells, Cultured, Fibroblasts, Humans, Mice, Inbred C57BL, Pancreatic Neoplasms, Cytokines, Carcinoma, Pancreatic Ductal, STAT3 Transcription Factor, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.